CC2-17887-15146
2 vaccinations
2 coded responses
13 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 930 / CA
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-18
- 2021-02-25
- 2021-04-16
-
2021-07-15
Survey response — 6 months, dose 2MedDRA: Bronchospasm, Cough, Illness, Pyrexia, Tracheobronchitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: 2 weeks ago developed trachealbronchitis.Fever with Tmax 104.7 associated with bronchospasm and nonproductive cough. Fever lasted 36 hours, cough 6 days. Daily improvement from onset of illness. No chest pain, SOB. Resolved without sequela.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-01-14
Survey response — 12 months, dose 2MedDRA: Bronchitis, Nasal congestion, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: GoodFree text: Had positive SARS CoV-2 antigen test on 12/31. Symptoms fever (TMAX 102.7) x 2 days followed by bronchitis and Rhinorrea for 5 days. Residual mild nasal congestion x 8 days.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech |
Free text
Release 9 — 6 months, dose 2
Symptoms: 2 weeks ago developed trachealbronchitis.Fever with Tmax 104.7 associated with bronchospasm and nonproductive cough. Fever lasted 36 hours, cough 6 days. Daily improvement from onset of illness. No chest pain, SOB. Resolved without sequela.
Release 10 — 12 months, dose 2
Symptoms: Had positive SARS CoV-2 antigen test on 12/31. Symptoms fever (TMAX 102.7) x 2 days followed by bronchitis and Rhinorrea for 5 days. Residual mild nasal congestion x 8 days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | · | · | ✓ |
| SD | Bronchospasm | ✓ | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Illness | ✓ | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Pyrexia | ✓ | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Tracheobronchitis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release